Literature DB >> 9686021

[Persistent facial paralysis: contribution of imaging to identification of perineural infiltrating tumor].

H Ben Hajel1, K Marsot-Dupuch, F Chabolle, M Ouayoun, B Meyer, L Brunereau, J M Tubiana.   

Abstract

To describe imaging features suggestive of retrograde perineural spread in progressive facial palsy without known tumoral origin. Two reports of perineural infiltration by salivary malignant tumors were diagnosed on abnormal enhancement of the facial nerve associated with an abnormal nerve enlargement (1/2). These unsuspected tumors were located in parotid gland (1/2) and the sub-maxillary gland (1/2). ENT tumors (especially adenoid cystic carcinomas) should be carefully searched in case of perineural spread, as these tumors may be misdiagnosed due to their size, location and signal. Therefore, imaging studies of facial palsy should include temporal bone, skull base, parotid gland, submaxillary gland and sub cutaneous areas of the face. A sub-maxillary gland tumor should be searched in case of facial palsy associated with glossodynia.

Entities:  

Mesh:

Year:  1997        PMID: 9686021

Source DB:  PubMed          Journal:  Ann Otolaryngol Chir Cervicofac        ISSN: 0003-438X


  3 in total

Review 1.  Salivary gland myoepithelial carcinoma.

Authors:  S Vilar-González; K Bradley; J Rico-Pérez; P Vogiatzis; D Golka; A Nigam; M Sivaramalingam; S Kazmi
Journal:  Clin Transl Oncol       Date:  2015-07-02       Impact factor: 3.405

2.  The radiologic (CT/MRI)-pathological correlations of the salivary duct carcinoma (SDC) with hyaline degeneration and peripheral nerve invasion.

Authors:  Nobukata Kazawa; Yuta Shibamoto; Yasujirou Hirose; Yoriko Yamashita
Journal:  Dentomaxillofac Radiol       Date:  2021-04-20       Impact factor: 3.525

3.  Metastatic parotid myoepithelial carcinoma in a 7-year-old boy.

Authors:  Issam Saliba; Nazir El Khatib; Antoine Nehme; Selim Nasser; Nabil Moukarzel
Journal:  Case Rep Pediatr       Date:  2012-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.